Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial
Authors
Frederick W. Unverzagt (ORCID: https://orcid.org/0000-0001-9297-1186)
Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial
Frederick W. Unverzagt, Malaz Boustani, Noll L. Campbell, Khalid A. Alamer et al.
Journal
Trials
Topics
Intensive Care Unit Cognitive Disorders
article
Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial
Frederick W. Unverzagt, Malaz Boustani, Noll L. Campbell, Khalid A. Alamer, Christopher Pitts, Sujuan Gao, Kathleen A. Lane, N. Manoharan, David S. H. Rosenthal, Sneha Manoharan, Addison B. Harrington, Allie Carter, Hussein Khalil, Richard Holden, Noha Keshk, Kathryn Pelkey, Emily Papineau, David M. Lauck
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 25(1)
Institutions
Indiana University Health (US), Regenstrief Institute (US), University of Indianapolis (US), Purdue University West Lafayette (US), Indiana University Bloomington (US), Community Health Network (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US), Imam Abdulrahman Bin Faisal University (SA)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial — Frederick W. Unverzagt, Malaz Boustani, et al. · Trials (2024) | TGRS Research Map | TGRS